Cargando…
Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine: results from a population-based prospective cohort in Catalonia, Spain, 2020
BACKGROUND: Several clinical trials have assessed the protective potential of chloroquine and hydroxychloroquine. Chronic exposure to such drugs might lower the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or severe coronavirus disease (COVID-19). AIM: To asses...
Autores principales: | Vivanco-Hidalgo, Rosa Maria, Molina, Israel, Martinez, Elisenda, Roman-Viñas, Ramón, Sánchez-Montalvá, Adrián, Fibla, Joan, Pontes, Caridad, Velasco Muñoz, César |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934222/ https://www.ncbi.nlm.nih.gov/pubmed/33663646 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.9.2001202 |
Ejemplares similares
-
Early Access to Medicines: Use of Multicriteria Decision Analysis (MCDA) as a Decision Tool in Catalonia (Spain)
por: Gasol, Montse, et al.
Publicado: (2022) -
Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014) -
Chloroquine/hydroxychloroquine overdose
por: McKeever, Rita
Publicado: (2020) -
HTLV-1/2 Infection in Blood Donors from a Non-Endemic Area (Catalonia, Spain) between 2008 and 2017: A 10-Year Experience
por: Piron, Maria, et al.
Publicado: (2022) -
Chloroquine and hydroxychloroquine for cancer therapy
por: Manic, Gwenola, et al.
Publicado: (2014)